Loading...
STFS is not a good buy right now. With no proprietary buy signals, weakening/soft technicals, and pattern-based odds pointing to further downside over the next week/month, the better action is to avoid new entries (and sell if you’re holding).
Price/Trend: Trading around $0.1143 post-market after a -2.40% regular-session drop (and -2.13% pre-market), which keeps the near-term tone weak. Momentum: MACD histogram is above zero (0.00135) but positively contracting—bullish momentum is fading rather than strengthening. RSI: RSI(6) ~40.2, below the midline and leaning bearish/soft (not oversold enough to suggest a high-confidence rebound). Moving Averages: Converging MAs suggests indecision/transition, but without upside follow-through. Key Levels: Pivot ~0.119 (current price below pivot = bearish bias). Support S1 ~0.106 then S2 ~0.0988. Resistance R1 ~0.131 then R2 ~0.138. Forward Pattern Odds: Similar-pattern study implies a 70% chance of -0.19% next day, -2.85% next week, and -3.61% next month—skewed to continued drift lower.
Intellectia Proprietary Trading Signals
and holds, a short-term technical bounce toward ~0.131 could develop, but this is not confirmed.
and fading MACD momentum. Pattern-based outlook leans negative over 1W/1M horizons. Lack of fresh news/catalysts reduces the probability of a quick upside move. Broader market tailwind is not supportive (S&P 500 slightly down, -0.07%).
Financial data not available (snapshot returned an error), so the latest quarter performance and growth trends cannot be assessed from the provided dataset (latest quarter season not provided).
No analyst rating/price target change data was provided, so there is no observable recent trend in Wall Street ratings or targets. Pros/cons view from analysts cannot be determined from the dataset. Hedge funds and insiders are reported as Neutral with no significant recent trading trends. Congress trading: No recent congress trading data available.
